Prognostic Impact of Diffuse Large B-Cell Lymphoma Subgroups in Patients Undergoing Autologous SCT

Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2008.330
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Prognostic Biomarkers in Diffuse Large B-Cell Lymphoma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2006English

Prognostic Nomogram for Overall Survival in Patients With Diffuse Large B‐Cell Lymphoma

Oncologist
Cancer ResearchMedicineOncology
2019English

PKC-beta II Expression Has Prognostic Impact in Nodal Diffuse Large B-Cell Lymphoma

Modern Pathology
Forensic MedicinePathology
2007English

Prognostic Significance of Serum Immunoglobulin Paraprotein in Patients With Diffuse Large B Cell Lymphoma

British Journal of Haematology
Hematology
2017English

Prognostic Impact of a Past or Synchronous Second Cancer in Diffuse Large B Cell Lymphoma

Blood Cancer Journal
OncologyHematology
2018English

Diffuse Large B-Cell Lymphoma

2020English

Prognostic Significance of Serum Aspartic Transaminase in Diffuse Large B-Cell Lymphoma

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Prognostic Value of Baseline FDG Pet Parameters in High Risk Diffuse Large B-Cell Lymphoma Patients

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

The Negative Prognostic Significance of Serum Immunoglobulin Paraprotein in Patients With Diffuse Large B Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy